https://www.selleckchem.com/pr....oducts/chir-99021-ct
ature of spermatogenesis in NOA population by assessing the possible presence of sperm after mTESE.OBJECTIVES The loss of skeletal muscle mass is widely considered a predictor of poor survival and toxicity in breast cancer patients. The aim of this study is to evaluate if there is pectoralis muscle area (PMA) variation, reflecting loss of skeletal muscle mass, on consecutive MRI examinations after neoadjuvant chemotherapy. METHODS The retrospective study protocol was approved by our institutional review board. A total of
Like
Comment
Share
